Clinical Drug Experience Knowledgebase

Adenocarcinoma (Phase 1)

Adenocarcinoma, Clear Cell (Phase 2)

Adenomyoepithelioma (Phase 2)

Breast Neoplasms (Phase 2)

Carcinoma (Phase 2)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Ovarian Epithelial (Phase 1)

Carcinoma, Renal Cell (Phase 2)

Carcinoma, Squamous Cell (Phase 2)

Cholangiocarcinoma (Phase 1)

Colorectal Neoplasms (Phase 1)

Fallopian Tube Neoplasms (Phase 1)

Glioblastoma (Phase 3)

Glioma (Phase 2)

Gliosarcoma (Phase 3)

Glomerulonephritis (Phase 1)

Glomerulonephritis, Membranoproliferative (Phase 1)

Head and Neck Neoplasms (Phase 1)

Hodgkin Disease (Phase 2)

Kidney Diseases (Phase 2)

Kidney Neoplasms (Phase 2)

Leukemia (Phase 2)

Leukemia, Lymphocytic, Chronic, B-Cell (Phase 2)

Leukemia, Lymphoid (Phase 1)

Leukemia, Myelogenous, Chronic, BCR-ABL Positive (Phase 2)

Leukemia, Myeloid (Phase 2)

Leukemia, Myeloid, Acute (Phase 2)

Liver Neoplasms (Phase 1)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 2)

Lymphoma, B-Cell (Phase 2)

Lymphoma, B-Cell, Marginal Zone (Phase 1)

Lymphoma, Large B-Cell, Diffuse (Phase 1)

Lymphoma, Mantle-Cell (Phase 1)

Lymphoma, Non-Hodgkin (Phase 2)

Melanoma (Phase 2)

Myelodysplastic Syndromes (Phase 2)

Neoplasms (Phase 2)

Neoplasms by Histologic Type (Phase 2)

Ovarian Neoplasms (Phase 1)

Pancreatic Neoplasms (Phase 2)

Precursor Cell Lymphoblastic Leukemia-Lymphoma (Phase 2)

Prostatic Neoplasms (Phase 1)

Squamous Cell Carcinoma of Head and Neck (Phase 2)

Thyroid Diseases (Phase 1)

Thyroid Neoplasms (Phase 1)

Triple Negative Breast Neoplasms (Phase 2)

Urinary Bladder Neoplasms (Phase 2)

Urogenital Neoplasms (Phase 2)

Urologic Diseases (Phase 2)

Urologic Neoplasms (Phase 2)

Urticaria (Phase 1)